Corneal Reconstruction with EGFP-Labelled Limbal Mesenchymal Stem Cells in a Rabbit Model of Limbal Stem Cell...

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Biomaterials Science

Background:

• Ocular surface reconstruction is crucial for vision restoration in corneal epithelial defects.
• Stem cell therapy shows promise but requires understanding in vivo cell behavior post-transplantation.
• Investigating limbal mesenchymal stem cell (L-MSC) fate is key for optimizing corneal regeneration strategies.

Purpose of the Study:

• To evaluate corneal reconstruction and the fate of EGFP-labeled limbal mesenchymal stem cells (L-MSCs-EGFP) after transplantation.
• To assess the survival, migration, and differentiation of L-MSCs-EGFP in a rabbit model of limbal stem cell deficiency.
• To analyze the contribution of transplanted cells to corneal tissue restoration.

Main Methods:

• EGFP labeling of L-MSCs for tracking cell fate.
• Seeding L-MSCs-EGFP onto decellularized human amniotic membrane (dHAM).
• Transplantation of dHAM-L-MSCs-EGFP into rabbits with induced limbal stem cell deficiency.
• Analysis of cell localization, viability, and corneal regeneration using histology, immunohistochemistry, and confocal microscopy up to 3 months post-transplantation.

Main Results:

• EGFP-labeled cells were viable for up to 14 days post-transplantation.
• Significant corneal epithelialization (90%) was observed by day 90.
• No viable labeled cells were detected in the regenerated epithelium at 90 days, indicating low long-term survivability.
• Partial restoration of squamous corneal-like epithelium was achieved by day 30.

Conclusions:

• Transplanted L-MSCs-EGFP can promote partial corneal reconstruction, even with limited long-term survival.
• The study highlights the need for further research into optimizing transplantation conditions and understanding the mechanisms of corneal tissue restoration.
• This work provides a foundation for developing improved stem cell-based therapies for ocular surface diseases.